01 / Treatment delivery
Articulated arm & applicator
The support arm brings the applicator to the treatment area while keeping the clinical workspace open around the patient.
Veterinary device ready for sale
Veterinary Oncology Device
Market signalVeterinary market signal
US · AnnualUS · Annual snapshot
- Modeled annual revenueModeled with the SynergyMed ROI calculator at 16 dogs treated per week. Adjust procedure pricing and clinic costs for your own estimate.
- ~$2.5Mannual projection · 16 dogs per weekROI calculatorOpen ROI calculator
- Annual needAnnual oncology need
- 12M+new cases / yearcats & dogs · US
- Household reach
- 70%of US householdsown a pet
Inside the SynergyVet device
Inside SynergyVet
01 / Treatment delivery
Articulated arm & applicator
The support arm brings the applicator to the treatment area while keeping the clinical workspace open around the patient.
02 / Mobile platform
Purpose-built device enclosure
The wheeled enclosure brings the system into one clinic-ready footprint, with an integrated work surface for setup and control.
03 / Clinical interface
Medical-grade monitor
A medical-grade display keeps treatment information clear and within easy reach at the point of care.
Non-surgical pathway
What surgery introduces, SynergyVet leaves out
SynergyVet is designed to treat superficial tumors without a surgical incision, keeping surgery-associated wound burdens out of the treatment workflow.
Surgery-associated burden
Not part of the treatment path
Non-surgical treatment pathNo incision. No surgical wound to manage.
The SynergyVet pathway
From unmet need to clinic-ready care
Stage 01/ 04
12M+
new US cases / year
Stage 02/ 04
No incision
non-surgical treatment path
Stage 03/ 04
Precise
controlled energy delivery
Stage 04/ 04
Ready
quote requests open
01 — Need
The growing need for alternative treatment
There are over 12,000,000 new cancer cases per year for cats and dogs in the US. About 70% of US households own a pet. Surgical solutions are risky due to bleeding complications, infections, wound dehiscence, and dirty margins.
- Companion animal demand
- Surgical burden reduction
- Owner-friendly recovery
02 — Solution
Non-Surgical Solution - SynergyMed
The non-surgical solution of SynergyMed will serve an unmet need for veterinary companion animals and horses with superficial solid tumors.
- Dogs
- Cats
- Horses
- Superficial solid tumors
03 — Technology
Revolutionizing treatment with advanced technology
Our veterinary device utilizes cutting-edge technology, providing a noninvasive, precise, and effective way to treat superficial solid tumors in companion animals and wildlife.
- Controlled heating
- Hyperthermia concepts
- Thermal ablation strategy
04 — Commercial
Device ready for sale
The veterinary device is ready for sale. Clinics, distributors, investors, and research partners can use the order and contact pages to start the discussion with the SynergyMed team.
- Quote requests open
- Distributor discussions
- Clinic procurement path
- Need01 · Need
- Solution02 · Solution
- Tech03 · Technology
- Ready04 · Commercial
01 · Need
The growing need for alternative treatment
There are over 12,000,000 new cancer cases per year for cats and dogs in the US. About 70% of US households own a pet. Surgical solutions are risky due to bleeding complications, infections, wound dehiscence, and dirty margins.
02 · Solution
Non-Surgical Solution - SynergyMed
The non-surgical solution of SynergyMed will serve an unmet need for veterinary companion animals and horses with superficial solid tumors.
03 · Technology
Revolutionizing treatment with advanced technology
Our veterinary device utilizes cutting-edge technology, providing a noninvasive, precise, and effective way to treat superficial solid tumors in companion animals and wildlife.
04 · Commercial
Device ready for sale
The veterinary device is ready for sale. Clinics, distributors, investors, and research partners can use the order and contact pages to start the discussion with the SynergyMed team.
Clinical studies
Promising outcomes and a clear path to get involved
Our technology has shown excellent results in clinical studies on dogs where the tumors were diminished within a few days to a week after the treatment.
Mast cell tumors
Mammary tumors
Carcinoma
Soft tissue sarcoma
A 6-year-old dog with breast cancer tumor was treated by SynergyMed technology. The dog is healthy and happy.
Care transformation
Transforming Veterinary Cancer Care
Our innovative device is transforming the way we treat cancer in animals, giving veterinarians new tools to provide safer and more effective care for our beloved pets.
FAQ
Veterinary Oncology FAQ
These answers strengthen relevance for the veterinary disease areas and technology terms most likely to drive qualified visits.
What veterinary oncology conditions are most relevant to SynergyMed?
The strongest veterinary search topics for SynergyMed include mast cell tumors, mammary tumors, carcinoma, soft tissue sarcoma, superficial tumors, and other solid tumor use cases in dogs, cats, and horses.
Why is a non-surgical option valuable in veterinary oncology?
Veterinary teams and pet owners often need alternatives that reduce surgical burden, minimize wound complications, and support better recovery for companion animals with superficial solid tumors.
How does the platform relate to hyperthermia and thermal ablation?
The veterinary device strategy is built around controlled heating, hyperthermia, and thermal ablation concepts that can be adapted to oncology workflows requiring precise treatment delivery.
Can commercial partners or clinics contact SynergyMed directly?
Yes. The veterinary device is ready for sale, and clinics, distributors, investors, and research partners can use the order and contact pages to start the discussion with the SynergyMed team.
Commercial next step
Ready to evaluate the veterinary device?
The device is ready for sale. Start with a quote request or contact the team for clinic, distributor, investor, or research partner discussions.